Coronavirus Disease (COVID-19) : Situation Report - 178
Coronavirus Disease (COVID-19) : Situation Report - 178
Coronavirus Disease (COVID-19) : Situation Report - 178
(COVID-19)
Situation Report – 178
Data as received by WHO from national authorities by 10:00 CEST, 16 July 2020
Highlights
75 countries have submitted expressions of interest to protect their populations and those
of other nations through joining the COVAX Facility, a mechanism designed to guarantee
rapid, fair and equitable access to COVID-19 vaccines worldwide. The goal of COVAX is to
deliver two billion doses of safe, effective vaccines that have passed regulatory approval and/or
WHO prequalification.
WHO and UNICEF have warned of a decline in vaccinations, due to disruptions in delivery
caused by the COVID-19 pandemic. UNICEF Executive Director Henrietta Fore noted that
“COVID-19 has made previously routine vaccination a daunting challenge” and stressed that
further impact on vaccine coverage needs to be avoided, otherwise there is a risk of exchanging
one crisis for another.
While the world races to find a vaccine to defeat the COVID-19 pandemic, WHO looks back on
all that vaccines have achieved for humanity.
In today’s ‘Subject in Focus’ we describe the WHO Unity Study protocols, developed to better
understand the characteristics of the COVID-19 virus and the disease it causes.
Thank you for reading the WHO COVID-19 Situation Report! We would greatly appreciate any
feedback and suggestions you may have on these reports via a short anonymous survey.
Globally 13 378 853 cases (226 181) 580 045 deaths (5 579)
Africa 523 403 cases (17 279) 8 819 deaths (172)
Americas 7 016 851 cases (132 700) 294 301 deaths (3 627)
Eastern Mediterranean 1 331 893 cases (14 815) 32 776 deaths (482)
Europe 2 987 256 cases (21 183) 205 006 deaths (552)
South-East Asia 1 268 923 cases (37 909) 31 297 deaths (727)
Western Pacific 249 786 cases (2 295) 7 833 deaths (19)
Subject in Focus: Unity studies: Early epidemiological investigations
for COVID-19
The identification of any new pathogen, such as SARS-CoV-2, the virus that causes COVID-19,
is accompanied by many unknowns. Six months into the pandemic, there are certain
characteristics of the virus and the disease it causes that remain unclear, particularly its ability
to spread in the human population and its virulence. To enhance understanding of the
characteristics of the COVID-19 (SARS-CoV-2) virus and the disease it causes, WHO has
developed a series of early epidemiological protocols, the WHO Unity studies. These protocols
enable analysis of the local context, as well as comparison across different settings.
The six currently available WHO Unity study protocols help countries to understand infection
amongst close contacts of cases, health workers, or members of households; to understand
the extent of infection in the population; and to determine the presence of the virus on
different surfaces and environments. The results of these studies help countries to inform
public health and social measures to limit further spread of the virus.
To date, 47 countries have implemented at least one of the Unity study protocols. An
additional 46 countries have expressed their intent to implement them. More than half of the
countries implementing the protocols (55%) are low- and middle-income countries, providing
an invaluable tool for enhanced surveillance and research equity.
WHO supports countries to develop and implement country-specific protocols, support
selection of laboratory tests, and ensure comparability of results between countries. WHO has
also procured and delivered laboratory tests to countries that have begun to implement at
least one of the studies. This represents 35 820 laboratory tests being sent to 12 low- and
middle-income countries, with further tests to be sent to other countries in the coming
months. The use of the same laboratory tests across study sites will ensure that the results
from different sites can be compared.
Two protocols are currently being developed in collaboration with technical partners. One will
enable understanding of the extent of infection in schools and other educational institutions.
The other will address COVID-19 in closed settings, which include long term care facilities,
food processing plants, prisons, military barracks, and community venues.
Surveillance
Figure 1. Number of confirmed COVID-19 cases reported in the last seven days by country, territory or area, 10 July to 16 July **
Case definitions
WHO periodically updates the Global Surveillance for human infection with coronavirus
disease (COVID-19) document which includes surveillance definitions.
Caution must be taken when interpreting all data presented. Differences are to be expected
between information products published by WHO, national public health authorities, and
other sources using different inclusion criteria and different data cut-off times. While steps
are taken to ensure accuracy and reliability, all data are subject to continuous verification and
change. Case detection, definitions, testing strategies, reporting practice, and lag times differ
between countries/territories/areas. These factors, amongst others, influence the counts
presented, with variable underestimation of true case and death counts, and variable delays
to reflecting these data at global level.
The designations employed, and the presentation of these materials do not imply the
expression of any opinion whatsoever on the part of WHO concerning the legal status of any
country, territory or area or of its authorities, or concerning the delimitation of its frontiers or
boundaries. Dotted and dashed lines on maps represent approximate border lines for which
there may not yet be full agreement. Countries, territories and areas are arranged under the
administering WHO region.
The mention of specific companies or of certain manufacturers’ products does not imply that
they are endorsed or recommended by WHO in preference to others of a similar nature that
are not mentioned. Errors and omissions excepted, the names of proprietary products are
distinguished by initial capital letters.
[1]
All references to Kosovo should be understood to be in the context of the United Nations
Security Council resolution 1244 (1999). In the map, number of cases of Serbia and Kosovo
(UNSCR 1244, 1999) have been aggregated for visualization purposes.
Due to the recent trend of countries conducting data reconciliation exercises which remove
large numbers of cases or deaths from their total counts, WHO will now display such data as
negative numbers in the “new cases” / “new deaths” columns as appropriate. This will aid
readers in identifying when such adjustments occur. When additional details become
available that allow the subtractions to be suitably apportioned to previous days, graphics will
be updated accordingly. Prior situation reports will not be edited; see covid19.who.int for the
most up-to-date data.
Additional table notes
i
Transmission classification is based on a process of country/territory/area self-reporting.
Classifications are reviewed on a weekly basis and may be revised as new information
becomes available. Differing degrees of transmission may be present within
countries/territories/areas; classification is based on the highest category reported within a
country/territory/area. Categories: